This Action aims at using innovative translational research to identify colorectal cancer biomarkers for personalized medicine that will improve screening, early detection and disease follow-up, and attain better tumor profiling, state-of-the-art functional characterization of genetic variants and new therapy approaches

Read more

  • Cooperation studies on inherited susceptibility to colorectal cancer
  • TRANSCOLONCAN Group
  • Graphic

News

COST event "Future of European Cancer Research" to be held next week

Monday, 20 May 2019

TRANSCOLONCAN's vice-chair, Richarda de Voer, will attend an interactive event "Future of European Cancer Research" that will be organized by the COST Association in Brussels on 21 and 22 May 2019

More about "COST event "Future of European Cancer Research" to be held next week"


COST is supported by the EU Framework Programme Horizon 2020